About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,349 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,349 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 561-580 of 3,349 trials

TerminatedRiluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by SurgeryRATIONALE: Riluzole may stop or slow the growth of tumor cells and may be an effective treatment for melanoma.NCT00667901·New Brunswick, New Jersey CompletedExercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor TreatmentCheckpoint inhibitors like the PD-1 antibodies Pembrolizumab and Nivolumab represent standard of care for patients with metastasized melanoma.NCT03171064·Heidelberg UnknownEndostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous MelanomaThe goal of this clinical trial is to evaluate the efficacy and safety of Endostar combined with Toripalimab in the adjuvant treatment of resectable stage III-oligometastatic…NCT05907512·Shanghai

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

TerminatedStudy of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant MelanomaThis is a multicenter Phase 1b, open-label study to evaluate the pharmacokinetic, safety and efficacy of binimetinib and encorafenib co-administered to adolescent patients with…NCT03878719·Milan, Lombardy

CompletedTrial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV MelanomaThe purpose of this study is to test the safety of an investigational combination drug/immunotherapy for the treatment of Stage III/IV melanoma.NCT00815607·Santa Monica, California and 7 others

Active not recruitingA Study to Test the Benefit of Vitamin B5 in Patients With MelanomaThis study is open to patients with a type of cancer called melanoma.NCT06377111·Toronto, Ontario

TerminatedCMP-001 in Combination With Nivolumab in Subjects With Advanced MelanomaCMP-001-010 is a Phase 2 study of CMP-001 intratumoral (IT) and nivolumab intravenous (IV) administered to participants with refractory unresectable or metastatic melanoma.NCT04698187·Phoenix, Arizona and 24 others

CompletedA Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced MelanomaThis is a single arm, multicenter, open label, and non-randomized clinical study on adult participants with unresectable or metastatic melanoma.NCT02768207·Brussels and 13 others

Not yet recruitingPHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid ExposureExtracorporeal photopheresis (ECP) is an immunomodulatory therapy in which the photoactivating agent methoxsalen (also known as UVADEX) is used in combination with ultraviolet A…NCT07619898

UnknownHeat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor CellsThis study investigates the ability of heat shock protein HSP70 to isolate and quantify circulating tumor cells (CTCs) in patients with advanced or metastatic tumors.NCT04628806·Berlin

CompletedA Study of Tasisulam in Treating Participants With Malignant MelanomaThe primary purpose of this study is to determine the objective response rate (complete and partial response) for participants who receive tasisulam after one prior systemic…NCT00383292·Los Angeles, California and 12 others

CompletedA Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersThis is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects.NCT01460134·Scottsdale, Arizona and 9 others

UnknownIdentifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary MelanomaRATIONALE: Identifying gene mutations and other risk factors in patients with melanoma and in families with a history of hereditary melanoma may help doctors identify persons at…NCT00450593·Leeds, England

CompletedPilot Study Evaluating the Efficacy and Safety of Metformin in MelanomaIn western countries, melanoma represents a major mistake of public health by its frequency, lethality and the increasing of incidence.NCT01840007·Nice, Alpes-Maritimes and 1 other

CompletedA Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients1.NCT04911998·Evora

CompletedInterferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid TumorsRATIONALE: Interferon gamma may interfere with the growth of cancer cells and may be an effective treatment for melanoma and solid tumors.NCT00004016·Rochester, New York

CompletedVaccination of Patients With Stage IV Melanoma With Dendritic CellsThe purpose of this study is to test a novel dendritic cell (DC) vaccine in patients with Stage IV melanoma.NCT00125749·Dallas, Texas

CompletedCombination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic MelanomaThe combination of TMZ and DAC may effect dual modulation of DNA repair genes resulting in improved clinical response.NCT00715793·Pittsburgh, Pennsylvania

Active not recruitingStudy Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With PembrolizumabThis Phase 1/2, first-in-human, open-label, multicenter study follows a 3+3 ascending dose escalation design to determine the MTD/RP2D and to characterize the safety…NCT04130516·Los Angeles, California and 9 others

CompletedArtificial Intelligence Augmented Training in Skin Cancer Diagnostics for General PractitionersBackground: The worldwide incidence of skin cancer has been rising for 50 years, in particular the incidence of malignant melanoma has increased approx. 2-7% annually and is the…NCT04576416·Valby, Danmark

PreviousPage 29 of 168Next